KPV Research for Skin Inflammation
An evidence-based overview of research examining KPV in the context of skin inflammation. This page synthesizes findings from peer-reviewed literature.
Research Summary
KPV, derived from the anti-inflammatory portion of alpha-MSH, has been studied for skin inflammatory conditions. The peptide inhibits inflammatory pathways in keratinocytes and immune cells. Research demonstrates anti-inflammatory effects in models of contact dermatitis and other skin inflammation. The melanocortin system is known to modulate cutaneous immune responses. Topical KPV formulations are of interest but have not been clinically evaluated. The peptide's small size facilitates skin penetration.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Skin Inflammation
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. KPV has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.